Discover six key dietary strategies to reduce cancer risk, including garlic, broccoli, berries, turmeric, green tea, and tomatoes. These foods contain compounds with potential anti-cancer benefits and can be incorporated into a balanced diet for preventive health. Stay informed about recent advances in cancer therapies and always seek professional medical advice for personalized treatment options.

Six Nutritional Strategies to Lower Cancer Risk

Research indicates that diet plays a crucial role in cancer prevention by influencing various risk factors. Incorporating specific health-boosting foods into daily meals can significantly reduce the likelihood of developing certain cancers. Here are six dietary choices that may offer protective benefits against cancer development.

Garlic
Packed with allicin, a compound known for its anti-cancer properties, garlic consumption has been associated with a reduced risk of gastric cancers. Eating about one clove per day or two to five grams can be advantageous.

Broccoli
This vegetable contains sulforaphane, a compound with potential anti-cancer effects. Studies suggest that consuming broccoli may help reduce risks of colorectal and other cancers.

Berries
Rich in antioxidants, berries such as raspberries, strawberries, blackberries, and goji berries may contribute to the prevention of cancers like colorectal and esophageal types. They are potent natural protectors.

Turmeric
This bright-colored spice contains curcumin, which may suppress cancer cell growth, slow tumor progression, or induce tumor regression.

Green Tea
With abundant antioxidants including EGCG, green tea consumption has been linked to lower risks of cancers such as breast, liver, skin, lung, and pancreatic types.

Tomatoes
High in lycopene, tomatoes can help protect against prostate and lung cancers by neutralizing harmful free radicals. Adding tomatoes to your meals is recommended for cancer risk reduction.

For those diagnosed with cancer, integrating these nutrient-rich foods into their diet alongside medical treatments can be beneficial. Recently approved therapies include Lumakras, Neulasta, Ibrutinib, Venclexta, CAR T-cell therapy, KYPROLIS, and Xofigo, targeting various cancer types.

Notably, Lumakras received approval in 2021 for KRAS G12C-mutated non-small cell lung cancer. Neulasta helps replenish white blood cells after chemotherapy, while Ibrutinib and Venclexta target leukemia and lymphoma. CAR T-cell therapy customizes immune cells to fight cancer, whereas KYPROLIS and Xofigo focus on multiple myeloma and prostate cancer. BCMA therapies specifically target cancer cell receptors, offering new hope for multiple myeloma patients.

Always consult healthcare providers for tailored treatment plans and medical guidance.